+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Point of Care Testing Market - Global Forecast 2026-2032- Product Image
Point of Care Testing Market - Global Forecast 2026-2032- Product Image
New

Point of Care Testing Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 191 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 4968870
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The point of care testing market is in transition, driven by shifting healthcare delivery models and advances in diagnostic technologies. These developments are enabling hospitals, laboratories, and clinical teams to accelerate diagnostics and support real-time decision-making.

Market Snapshot: Robust Growth in Point of Care Testing

The global point of care testing market is witnessing rapid expansion, increasing from USD 37.13 billion in 2025 to USD 41.99 billion in 2026, with a projected compound annual growth rate of 13.61%. This momentum is expected to bring the market to USD 90.76 billion by 2032. Demand is intensifying as healthcare organizations prioritize immediate diagnostics, leveraging advances in mobile health devices and broadening adoption in both clinical and home settings. These shifts are facilitating faster clinical responses and enhancing flexibility for healthcare providers worldwide.

Scope & Segmentation: Comprehensive View of the Point of Care Testing Market

This report offers thorough analysis for senior decision-makers assessing investment opportunities, technology adoption, and procurement strategies within the point of care testing sector. The segmentation below provides a framework to evaluate trends, supplier positioning, and market opportunities:

  • Product Families: Includes consumables, services and software, instruments and analyzers, as well as reagents and assays, covering the breadth of laboratory and patient-facing applications.
  • Test Types: Covers blood gases and metabolic panels, cardiac markers, drug of abuse screening, hematology (inclusive of various subtypes), infectious diseases, molecular diagnostics, pregnancy and fertility, and urinalysis, each addressing distinct clinical needs.
  • Sample Types: Incorporates blood, nasal and swab samples, saliva, and urine, reflecting the range of suitable patient contexts and collection methods.
  • Technologies: Encompasses biosensors, colorimetric platforms, immunoassays, lateral flow (singleplex and multiplex), microfluidics, PCR-based, and molecular diagnostic platforms, all key to accurate and rapid test delivery.
  • Portability: Spans benchtop analyzers for stationary use and handheld or portable devices supporting care across remote or distributed settings.
  • Purchasing Channels: Includes over-the-counter products and prescription-based solutions, accounting for distribution flexibility across clinical and non-clinical environments.
  • Applications: Touches on chronic disease management, emergency and critical care, infectious disease diagnosis, occupational testing, oncology monitoring, and solutions for women’s health.
  • End Users: Caters to hospitals, clinics, ambulatory care centers, diagnostic labs, urgent care providers, stand-alone emergency departments, and home care settings, each with unique operational needs.
  • Distribution Channels: Encompasses direct sales, distributors, wholesalers, retail, pharmacy, and online platforms, supporting both business-to-business and business-to-consumer models.
  • Regions Covered: Analyzes the Americas, Europe Middle East & Africa, and Asia-Pacific, highlighting regional differences in adoption, regulatory landscape, and commercial approaches.

Within each segment, the research explores how emerging technologies and adaptable testing platforms are shaping clinical pathways and improving responsiveness to evolving patient care requirements.

Key Takeaways: Strategic Insights for Decision-Makers

  • Molecular diagnostics and biosensor-enabled platforms are enabling prompt access to diagnostic results outside of traditional laboratories, accelerating clinical workflows and decentralizing care.
  • Healthcare buyers increasingly prefer platforms that are connected, intuitive, and designed for use in decentralized or home-based settings, reflecting a growing emphasis on accessibility and usability.
  • Regional factors such as regulatory regimes and healthcare funding models impact adoption rates and shape distribution strategies, making strong local relationships and adaptable infrastructure critical.
  • Procurement strategies are evolving toward value-based assessments and measurable clinical outcomes, with data integration and interoperability considered essential for technology adoption.
  • Competitive differentiation is progressing toward integrated hardware, reagent, and software solutions, with managed service models and strategic alliances gaining importance in long-term planning.
  • Manufacturers must balance technical performance and innovation with compliance requirements and shifting commercialization priorities in a complex and segmented global market.

Tariff Impact: Navigating Complex Supply Chains

Changes in import tariffs are directly affecting supply chain costs and vendor management strategies within the point of care testing sector. Organizations are adapting by revising supplier contracts, expanding regional manufacturing capabilities, and refining sourcing strategies. These efforts center on managing risk and ensuring continued access to innovative diagnostic products while maintaining operational agility. Diversifying supplier networks and implementing risk mitigation measures remain vital for minimizing tariff-related disruptions and sustaining momentum in product development and delivery.

Methodology & Data Sources

Research findings result from structured primary interviews with industry stakeholders, supplemented by a thorough proprietary literature review and scenario-driven analysis. The methodology integrates feedback from end-users, supplier executives, and regulatory bodies and triangulates insights using public disclosures and peer-reviewed market studies.

Why This Report Matters: Actionable Intelligence for Stakeholders

  • Supports manufacturers and providers in aligning innovative diagnostic technologies and commercial approaches in a dynamic, evolving marketplace.
  • Equips procurement and operational leaders with segmentation intelligence to address regional, technological, and end-user differences, driving informed investment and supplier decisions.
  • Enables strategy formulation for supply chain resilience, regulatory compliance, and partnership building to respond effectively to market and policy changes.

Conclusion

Point of care testing is advancing as technology, workflow optimization, and flexible commercial models shape market progress. Stakeholders focusing on resilient supply chains and collaborative integration will be well placed for leadership as the market evolves.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Point of Care Testing Market, by Product
8.1. Consumables Services & Software
8.1.1. Consumables & Accessories
8.1.2. Service Maintenance & Calibration
8.1.3. Software & Connectivity
8.2. Instruments & Analyzers
8.2.1. Benchtop Analyzers
8.2.2. Molecular Platforms
8.2.3. Portable Analyzers
8.2.4. Readers & Scanners
8.3. Reagents & Assays
8.3.1. Glucose Test Strips
8.3.2. Hematology Reagents
8.3.3. Immunoassay Reagents
8.3.4. Lateral Flow Assay Reagents
8.3.5. Molecular Assay Kits
9. Point of Care Testing Market, by Test Type
9.1. Blood Gases
9.2. Cardiac Markers
9.2.1. B-type Natriuretic Peptide
9.2.2. Troponin
9.3. Comprehensive Metabolic Panel
9.4. Drug Of Abuse Testing
9.5. Hematology
9.5.1. Coagulation Tests
9.5.1.1. Activated Partial Thromboplastin Time
9.5.1.2. Fibrinogen Level
9.5.1.3. Prothrombin Time & International Normalized Ratio
9.5.2. Complete Blood Count
9.6. Infectious Disease
9.6.1. Gastrointestinal Infection Tests
9.6.2. Respiratory Infection Tests
9.6.3. Sexually Transmitted Infection Tests
9.7. Molecular Diagnostics
9.8. Pregnancy & Fertility
9.9. Urinalysis
10. Point of Care Testing Market, by Sample Type
10.1. Blood
10.2. Nasal & Swab Samples
10.3. Saliva
10.4. Urine
11. Point of Care Testing Market, by Technology
11.1. Biosensor Electrochemical
11.2. Colorimetric Platforms
11.3. Immunoassay
11.4. Lateral Flow Assays
11.4.1. Antibody Tests
11.4.2. Antigen Tests
11.4.3. Multiplex Lateral Flow
11.5. Microfluidics
11.6. PCR And Molecular
12. Point of Care Testing Market, by Portability
12.1. Benchtop Fixed Analyzers
12.2. Portable Handheld Devices
13. Point of Care Testing Market, by Mode of Purchase
13.1. Over-The-Counter Tests
13.2. Prescription-Based Tests
14. Point of Care Testing Market, by Application
14.1. Chronic Disease Management
14.2. Emergency And Critical Care
14.3. Infectious Disease Diagnosis
14.4. Occupational And Workplace Testing
14.5. Oncology Monitoring
14.6. Women Health
15. Point of Care Testing Market, by End User
15.1. Ambulatory Care Centers
15.2. Diagnostic Laboratories
15.3. Free-Standing Emergency Departments
15.4. Home Care
15.5. Hospitals & Clinics
15.6. Urgent Care Centers
16. Point of Care Testing Market, by Distribution Channel
16.1. Offline
16.1.1. Direct Sales
16.1.2. Distributor & Wholesale
16.1.3. Retail & Pharmacy
16.2. Online
17. Point of Care Testing Market, by Region
17.1. Americas
17.1.1. North America
17.1.2. Latin America
17.2. Europe, Middle East & Africa
17.2.1. Europe
17.2.2. Middle East
17.2.3. Africa
17.3. Asia-Pacific
18. Point of Care Testing Market, by Group
18.1. ASEAN
18.2. GCC
18.3. European Union
18.4. BRICS
18.5. G7
18.6. NATO
19. Point of Care Testing Market, by Country
19.1. United States
19.2. Canada
19.3. Mexico
19.4. Brazil
19.5. United Kingdom
19.6. Germany
19.7. France
19.8. Russia
19.9. Italy
19.10. Spain
19.11. China
19.12. India
19.13. Japan
19.14. Australia
19.15. South Korea
20. United States Point of Care Testing Market
21. China Point of Care Testing Market
22. Competitive Landscape
22.1. Market Concentration Analysis, 2025
22.1.1. Concentration Ratio (CR)
22.1.2. Herfindahl Hirschman Index (HHI)
22.2. Recent Developments & Impact Analysis, 2025
22.3. Product Portfolio Analysis, 2025
22.4. Benchmarking Analysis, 2025
22.5. Abaxis, Inc. by Zoetis Inc
22.6. Abbott Laboratories
22.7. AccuBioTech Co., Ltd.
22.8. ACON Laboratories, Inc.
22.9. Beckman Coulter
22.10. Becton, Dickinson and Company
22.11. Bio-Rad Laboratories, Inc.
22.12. bioMérieux SA
22.13. CardioGenics Holdings Inc.
22.14. Chembio Diagnostic Systems, Inc. by Biosynex
22.15. Danaher Corporation
22.16. EKF Diagnostics Holdings
22.17. F. Hoffmann-La Roche Ltd
22.18. GE Healthcare Technologies, Inc.
22.19. Medtronic Plc
22.20. Nova Biomedical Corporation
22.21. OraSure Technologies, Inc.
22.22. Quidel Corporation
22.23. Radiometer Medical ApS
22.24. Randox Laboratories Ltd.
22.25. Siemens Healthineers AG
22.26. Thermo Fisher Scientific Inc.
List of Figures
FIGURE 1. GLOBAL POINT OF CARE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL POINT OF CARE TESTING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL POINT OF CARE TESTING MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY TEST TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PORTABILITY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 13. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 15. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. UNITED STATES POINT OF CARE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 17. CHINA POINT OF CARE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL POINT OF CARE TESTING MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY CONSUMABLES SERVICES & SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY CONSUMABLES SERVICES & SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY CONSUMABLES SERVICES & SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY CONSUMABLES SERVICES & SOFTWARE, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY CONSUMABLES & ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY CONSUMABLES & ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY CONSUMABLES & ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY SERVICE MAINTENANCE & CALIBRATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY SERVICE MAINTENANCE & CALIBRATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY SERVICE MAINTENANCE & CALIBRATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY SOFTWARE & CONNECTIVITY, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY SOFTWARE & CONNECTIVITY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY SOFTWARE & CONNECTIVITY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY INSTRUMENTS & ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY INSTRUMENTS & ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY INSTRUMENTS & ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY INSTRUMENTS & ANALYZERS, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY BENCHTOP ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY BENCHTOP ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY BENCHTOP ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY MOLECULAR PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY MOLECULAR PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY MOLECULAR PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PORTABLE ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PORTABLE ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PORTABLE ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY READERS & SCANNERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY READERS & SCANNERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY READERS & SCANNERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY REAGENTS & ASSAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY REAGENTS & ASSAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY REAGENTS & ASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY REAGENTS & ASSAYS, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY GLUCOSE TEST STRIPS, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY GLUCOSE TEST STRIPS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY GLUCOSE TEST STRIPS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY HEMATOLOGY REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY HEMATOLOGY REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY HEMATOLOGY REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY IMMUNOASSAY REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY IMMUNOASSAY REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY IMMUNOASSAY REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY LATERAL FLOW ASSAY REAGENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY LATERAL FLOW ASSAY REAGENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY LATERAL FLOW ASSAY REAGENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY MOLECULAR ASSAY KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY MOLECULAR ASSAY KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY MOLECULAR ASSAY KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY BLOOD GASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY BLOOD GASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY BLOOD GASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY CARDIAC MARKERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY CARDIAC MARKERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY CARDIAC MARKERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY CARDIAC MARKERS, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY B-TYPE NATRIURETIC PEPTIDE, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY B-TYPE NATRIURETIC PEPTIDE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY B-TYPE NATRIURETIC PEPTIDE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY TROPONIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY TROPONIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY TROPONIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY COMPREHENSIVE METABOLIC PANEL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY DRUG OF ABUSE TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY DRUG OF ABUSE TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY DRUG OF ABUSE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY HEMATOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY COAGULATION TESTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY COAGULATION TESTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY COAGULATION TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY COAGULATION TESTS, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY ACTIVATED PARTIAL THROMBOPLASTIN TIME, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY ACTIVATED PARTIAL THROMBOPLASTIN TIME, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY ACTIVATED PARTIAL THROMBOPLASTIN TIME, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY FIBRINOGEN LEVEL, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY FIBRINOGEN LEVEL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY FIBRINOGEN LEVEL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PROTHROMBIN TIME & INTERNATIONAL NORMALIZED RATIO, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PROTHROMBIN TIME & INTERNATIONAL NORMALIZED RATIO, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PROTHROMBIN TIME & INTERNATIONAL NORMALIZED RATIO, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY COMPLETE BLOOD COUNT, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY COMPLETE BLOOD COUNT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY COMPLETE BLOOD COUNT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY INFECTIOUS DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY INFECTIOUS DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY GASTROINTESTINAL INFECTION TESTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY GASTROINTESTINAL INFECTION TESTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY GASTROINTESTINAL INFECTION TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY RESPIRATORY INFECTION TESTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY RESPIRATORY INFECTION TESTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY RESPIRATORY INFECTION TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTION TESTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTION TESTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY SEXUALLY TRANSMITTED INFECTION TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PREGNANCY & FERTILITY, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PREGNANCY & FERTILITY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PREGNANCY & FERTILITY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY URINALYSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY URINALYSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY URINALYSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY BLOOD, BY REGION, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY BLOOD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY NASAL & SWAB SAMPLES, BY REGION, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY NASAL & SWAB SAMPLES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY NASAL & SWAB SAMPLES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY SALIVA, BY REGION, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY SALIVA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY SALIVA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY URINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY URINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY URINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY BIOSENSOR ELECTROCHEMICAL, BY REGION, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY BIOSENSOR ELECTROCHEMICAL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY BIOSENSOR ELECTROCHEMICAL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY COLORIMETRIC PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY COLORIMETRIC PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY COLORIMETRIC PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY IMMUNOASSAY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY IMMUNOASSAY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, BY REGION, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY ANTIBODY TESTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY ANTIBODY TESTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY ANTIBODY TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY ANTIGEN TESTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY ANTIGEN TESTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY ANTIGEN TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY MULTIPLEX LATERAL FLOW, BY REGION, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY MULTIPLEX LATERAL FLOW, BY GROUP, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY MULTIPLEX LATERAL FLOW, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY MICROFLUIDICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY MICROFLUIDICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY MICROFLUIDICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PCR AND MOLECULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PCR AND MOLECULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PCR AND MOLECULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY BENCHTOP FIXED ANALYZERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY BENCHTOP FIXED ANALYZERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY BENCHTOP FIXED ANALYZERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PORTABLE HANDHELD DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PORTABLE HANDHELD DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PORTABLE HANDHELD DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2032 (USD MILLION)
TABLE 163. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY OVER-THE-COUNTER TESTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY OVER-THE-COUNTER TESTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 165. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY OVER-THE-COUNTER TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 166. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PRESCRIPTION-BASED TESTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 167. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PRESCRIPTION-BASED TESTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY PRESCRIPTION-BASED TESTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 169. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 171. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 172. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 173. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY EMERGENCY AND CRITICAL CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 174. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY EMERGENCY AND CRITICAL CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 175. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY EMERGENCY AND CRITICAL CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 176. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 177. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 178. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY INFECTIOUS DISEASE DIAGNOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 179. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY OCCUPATIONAL AND WORKPLACE TESTING, BY REGION, 2018-2032 (USD MILLION)
TABLE 180. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY OCCUPATIONAL AND WORKPLACE TESTING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 181. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY OCCUPATIONAL AND WORKPLACE TESTING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 182. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY ONCOLOGY MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 183. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY ONCOLOGY MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 184. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY ONCOLOGY MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 185. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY WOMEN HEALTH, BY REGION, 2018-2032 (USD MILLION)
TABLE 186. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY WOMEN HEALTH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 187. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY WOMEN HEALTH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 188. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 189. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY AMBULATORY CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 190. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY AMBULATORY CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 191. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY AMBULATORY CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 192. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 193. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 194. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 195. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY FREE-STANDING EMERGENCY DEPARTMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 196. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY FREE-STANDING EMERGENCY DEPARTMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 197. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY FREE-STANDING EMERGENCY DEPARTMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 198. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 199. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 200. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 201. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 202. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 203. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 204. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY URGENT CARE CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 205. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY URGENT CARE CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 206. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY URGENT CARE CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 207. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 208. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 209. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 210. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 211. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 212. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
TABLE 213. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 214. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 215. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTOR & WHOLESALE, BY REGION, 2018-2032 (USD MILLION)
TABLE 216. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTOR & WHOLESALE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 217. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTOR & WHOLESALE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 218. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY RETAIL & PHARMACY, BY REGION, 2018-2032 (USD MILLION)
TABLE 219. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY RETAIL & PHARMACY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 220. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY RETAIL & PHARMACY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 221. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 222. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 223. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 224. GLOBAL POINT OF CARE TESTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 225. AMERICAS POINT OF CARE TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 226. AMERICAS POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 227. AMERICAS POINT OF CARE TESTING MARKET SIZE, BY CONSUMABLES SERVICES & SOFTWARE, 2018-2032 (USD MILLION)
TABLE 228. AMERICAS POINT OF CARE TESTING MARKET SIZE, BY INSTRUMENTS & ANALYZERS, 2018-2032 (USD MILLION)
TABLE 229. AMERICAS POINT OF CARE TESTING MARKET SIZE, BY REAGENTS & ASSAYS, 2018-2032 (USD MILLION)
TABLE 230. AMERICAS POINT OF CARE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 231. AMERICAS POINT OF CARE TESTING MARKET SIZE, BY CARDIAC MARKERS, 2018-2032 (USD MILLION)
TABLE 232. AMERICAS POINT OF CARE TESTING MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
TABLE 233. AMERICAS POINT OF CARE TESTING MARKET SIZE, BY COAGULATION TESTS, 2018-2032 (USD MILLION)
TABLE 234. AMERICAS POINT OF CARE TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 235. AMERICAS POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 236. AMERICAS POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 237. AMERICAS POINT OF CARE TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2032 (USD MILLION)
TABLE 238. AMERICAS POINT OF CARE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 239. AMERICAS POINT OF CARE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2032 (USD MILLION)
TABLE 240. AMERICAS POINT OF CARE TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 241. AMERICAS POINT OF CARE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 242. AMERICAS POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 243. AMERICAS POINT OF CARE TESTING MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 244. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 245. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 246. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY CONSUMABLES SERVICES & SOFTWARE, 2018-2032 (USD MILLION)
TABLE 247. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY INSTRUMENTS & ANALYZERS, 2018-2032 (USD MILLION)
TABLE 248. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY REAGENTS & ASSAYS, 2018-2032 (USD MILLION)
TABLE 249. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 250. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY CARDIAC MARKERS, 2018-2032 (USD MILLION)
TABLE 251. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
TABLE 252. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY COAGULATION TESTS, 2018-2032 (USD MILLION)
TABLE 253. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 254. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 255. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 256. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2032 (USD MILLION)
TABLE 257. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 258. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2032 (USD MILLION)
TABLE 259. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 260. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 261. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 262. NORTH AMERICA POINT OF CARE TESTING MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 263. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 264. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 265. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY CONSUMABLES SERVICES & SOFTWARE, 2018-2032 (USD MILLION)
TABLE 266. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY INSTRUMENTS & ANALYZERS, 2018-2032 (USD MILLION)
TABLE 267. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY REAGENTS & ASSAYS, 2018-2032 (USD MILLION)
TABLE 268. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 269. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY CARDIAC MARKERS, 2018-2032 (USD MILLION)
TABLE 270. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
TABLE 271. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY COAGULATION TESTS, 2018-2032 (USD MILLION)
TABLE 272. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 273. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 274. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 275. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2032 (USD MILLION)
TABLE 276. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 277. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2032 (USD MILLION)
TABLE 278. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 279. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 280. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 281. LATIN AMERICA POINT OF CARE TESTING MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, BY CONSUMABLES SERVICES & SOFTWARE, 2018-2032 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, BY INSTRUMENTS & ANALYZERS, 2018-2032 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, BY REAGENTS & ASSAYS, 2018-2032 (USD MILLION)
TABLE 287. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, BY TEST TYPE, 2018-2032 (USD MILLION)
TABLE 288. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, BY CARDIAC MARKERS, 2018-2032 (USD MILLION)
TABLE 289. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, BY HEMATOLOGY, 2018-2032 (USD MILLION)
TABLE 290. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, BY COAGULATION TESTS, 2018-2032 (USD MILLION)
TABLE 291. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2032 (USD MILLION)
TABLE 292. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2032 (USD MILLION)
TABLE 293. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 294. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, BY LATERAL FLOW ASSAYS, 2018-2032 (USD MILLION)
TABLE 295. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
TABLE 296. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, BY MODE OF PURCHASE, 2018-2032 (USD MILLION)
TABLE 297. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 298. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 299. EUROPE, MIDDLE EAST & AFRICA POINT OF CARE TESTING MARKET

Companies Mentioned

The key companies profiled in this Point of Care Testing market report include:
  • Abaxis, Inc. by Zoetis Inc
  • Abbott Laboratories
  • AccuBioTech Co., Ltd.
  • ACON Laboratories, Inc.
  • Beckman Coulter
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMérieux SA
  • CardioGenics Holdings Inc.
  • Chembio Diagnostic Systems, Inc. by Biosynex
  • Danaher Corporation
  • EKF Diagnostics Holdings
  • F. Hoffmann-La Roche Ltd
  • GE Healthcare Technologies, Inc.
  • Medtronic Plc
  • Nova Biomedical Corporation
  • OraSure Technologies, Inc.
  • Quidel Corporation
  • Radiometer Medical ApS
  • Randox Laboratories Ltd.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages191
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 41.99 Billion
Forecasted Market Value ( USD ) by 2032 $ 90.76 Billion
Compound Annual Growth Rate13.6%
Regions CoveredGlobal
No. of Companies Mentioned23

Related Topics

Related Reports

Cardiac Point of Care Testing Market - Global Forecast 2026-2032 - Product Image

Cardiac Point of Care Testing Market - Global Forecast 2026-2032

  • Report
  • 181 Pages
  • Global
From
Point of Care Testing Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034 - Product Image

Point of Care Testing Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034

  • Report
  • 163 Pages
  • Global
From
Point of Care Testing Market by Product Type, Sample Type and Technology - Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading Company Profiles and Market Forecast, 2025-2035 - Product Image

Point of Care Testing Market by Product Type, Sample Type and Technology - Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading Company Profiles and Market Forecast, 2025-2035

  • Report
  • 205 Pages
  • Global
From
Neonatal Point of Care Testing Market Report 2025 - Product Image

Neonatal Point of Care Testing Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Point-of-Care-Testing (POCT) Market Report 2025 - Product Image

Point-of-Care-Testing (POCT) Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.